209 CUPRINS

134
Referinţe
1. Abe F., Hiraki T. Mechanistic role of ergosterol in membrane rigidity and cycloheximide
resistance in Saccharomyces cerevisiae.//Biochim. et Biophys. Acta, 2008, p. 1-10.
2. Aittoniemi J., Rog T., Niemela P. et. al. Major factor in sterols’ordering capability in
membranes.//J. Phys. Chem. B Lett., 2006, vol. 110(51), p. 25562-25564.
3. Albert P., Proal A., Marshall T. Vitamin D: The alternative hypothesis.//Autoimm. Rev.,
2009, vol. 8, p. 639-644.
4. Bikle D., Oda Y., Xie Z. Vitamin D and skin cancer: a problem in gene regulation.//J.
Steroid Biochem. Molec. Biol., 2005, vol. 97, p. 83-91.
5. Boland R., Skliar M., Curino A., Milanesi L. Vitamin D compounds in plants.//Plant. Sci.,
2003, vol. 164, p. 357-369.
6. Bunce Ch., Brown G., Hewison M. Vitamin D and Hematopoiesis.//Trends Endocrinol.
Metab., 1997, vol. 8, p. 245-251.
7. Burden R., Cooke D., Hargreaves J. Review - mechanism of action of herbicidal
and fungicidal compounds on cell membranes.//Pest. Manag. Science, 2006, vol. 30(2),
p. 125-140.
8. Cantorna M. Vitamin D and its role in immunology: multiple sclerosis, and in ammatory
bowel disease.//Prog. Biophys. Mol. Biol., 2006, vol. 92, p. 60-64.
9. Casey W., Keesler G., Parks L. Regulation of partitioned sterol biosynthesis in
Saccharomyces yeasts.//J. Bacteriol., 1992, vol. 174(22), p. 7283-7288.
10. Chen Y., Imrie C., Ryder K. Synthesis, characterization and polymerization of a pyrrolebased
chiral liquid crystal.//J. Mater. Sci. Lett., 2002, vol. 21(8), p. 595-597.
11. Daum G., Lees N., Bard M., Dickson R. Biochemistry, cell biology and molecular
biology of lipids of Saccharomyces cerevisiae.//Yeast, 1998, vol. 14, p. 1471-1510.
12. Deluca H. Overview of general physiologic features and functions of vitamin D. //Am.
J. Clin. Nutr., 2004, vol. 80, p. 1689-1696.
13. Dimitri P., Bishop N. Rickets.//Paediatrics and Child Health, 2007, vol. 17, p. 279-287.
14. Ebert R., Schutze N., Adamski J., Jakob F. Vitamin D signaling is modulated on multiple
levels in health and disease.//Molec. Cell. Endocrin., 2006, vol. 248, p. 149-159.
15. Fleet J. Molecular actions of vitamin D contributing to cancer prevention. //Molecular
Aspects of Medicine, 2008, vol. 29, p. 388-396.
16. Forman J., Bischoff-Ferrari H., Willett W. et al. Vitamin D intake and risk of incident
hypertension: results from three large prospective cohort studies.//Hypertension, 2005,
vol. 46, p. 676-682.
17. Foss Y. Vitamin D de ciency is the cause of common obesity.//Medical Hypotheses,
2009, vol. 72, p. 314-321.
18. Gao H., Tan T. Fed-batch fermentation for ergosterol production.//Process. Biochem.,
2003, vol. 39, p. 345-350.
19. Garland C., Garland F., Gorham E., Lipkin M. et al. The role of vitamin D in cancer
prevention.//Am. J. Public Health, 2006, vol. 96, p. 252-261.
20. Goltzman D., Miao D., Panda D., Hendy G. Effects of calcium and of the vitamin D
system on skeletal and calcium homeostasis: lessons from genetic models.//J. Steroid Biochem.
Molec. Biol., 2004, vol. 90, p. 485-489.
21. Holik M. Vitamin D: important for prevention of osteoporosis, cardiovascular heart
disease, type 1 diabetes, autoimmune diseases, and some cancers.//South Med. J., 2005, vol. 98,
p. 1024-1027.
22. Lamberg-Allardt Ch. Vitamin D in foods and as supplements.//Progress in Biophys.
Molec. Biol., 2006, vol. 92, p. 33-38.
23. Luong Q., Koef er P. Vitamin D compounds in leukemia.//Journal of Steroid Biochemistry